Both in Pharmaceuticals
AnaptysBio vs Korsana Biosciences
Over the past year ANAB returned −11.4% and KRSA returned +0.2%; their daily moves had a correlation of 0.22.
ANAB −11.4% KRSA +0.2%Growth of $1, one year, split-adjusted
| Metric | ANAB | KRSA |
|---|---|---|
| Price | $47.73 | $31.96 |
| Market cap | $1.43B | $1.46B |
| Today | +1.75% | +0.95% |
| 1 month | −3.0% | +4.0% |
| 6 months | −31.1% | — |
| Year to date | −1.5% | — |
| 1 year | +30.5% | — |
| Revenue growth (YoY) | −8.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −206.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.1× | — |
| Net cash | $286.5M | — |
| Dividend yield | — | — |
| Volatility (60d) | 41.0% | — |
| Short % of float | 30.6% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).